Marinus Pharma CS
(MRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,787 | 146,904 | 240,551 | 168,249 | 92,326 |
| Marketable Securities | 47,549 | 52,297 | N/A | N/A | N/A |
| Receivables | 5,234 | 11,693 | 6,348 | 3,398 | 3,000 |
| Inventories | 2,674 | 37 | 77 | 104 | N/A |
| TOTAL | $194,609 | $219,995 | $252,378 | $177,006 | $101,091 |
| Non-Current Assets | |||||
| PPE Net | 3,938 | 4,037 | 4,236 | 5,520 | 5,561 |
| Other Non-Current Assets | 2,653 | 2,785 | 2,904 | 2,315 | 2,725 |
| TOTAL | $6,591 | $6,822 | $7,140 | $7,835 | $8,286 |
| Total Assets | $201,200 | $226,817 | $259,518 | $184,841 | $109,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,556 | 1,321 | 1,020 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,302 | 4,466 | 4,461 | 1,622 | 3,299 |
| Accrued Expenses | 17,895 | 15,727 | 19,536 | 19,428 | 19,811 |
| TOTAL | $25,603 | $21,514 | $25,017 | $21,050 | $23,110 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,086 | 102,391 | 100,875 | 70,780 | 70,350 |
| Other Non-Current Liabilities | 18,172 | 17,827 | 17,626 | 11,007 | 11,114 |
| TOTAL | $118,258 | $120,218 | $118,501 | $81,787 | $81,464 |
| Total Liabilities | $143,861 | $141,732 | $143,518 | $102,837 | $104,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,610 | 50,548 | 49,665 | 37,197 | 37,199 |
| Common Shares | 51 | 50 | 50 | 37 | 37 |
| Retained earnings | -497,185 | -465,251 | -430,521 | -396,209 | -469,499 |
| Other shareholders' equity | -114 | 4,117 | 4,043 | 4,043 | 4,043 |
| TOTAL | $57,339 | $85,085 | $116,000 | $82,004 | $4,803 |
| Total Liabilities And Equity | $201,200 | $226,817 | $259,518 | $184,841 | $109,377 |